TokenPost·
Revolution Medicines Shares Rise About 6% After Q3 Results Beat
The company reaffirmed its 2026 GAAP operating expense range of $2.1 billion to $2.2 billion and posted a $1.90 per-share loss.
More news
- TokenPostDemocrats Flip Seven Senate Seats and at Least 24 House Districts
- TokenPostIsomorphic Labs Seeks About $5 Billion at About $50 Billion Valuation
- TokenPostTreasure Proposal Sets 173 Million MAGIC Ceiling for DePIN Fund
- TokenPostHecla Expects Keno Hill Throughput Near 300 Metric Tons a Day in Q4 2026
- Crypto BriefingIREN’s Texas data center for Microsoft falls behind schedule
- TokenPostJapan's Nikkei 225 Falls 6.72% as SoftBank Shares Slide 14%